Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18,322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Profiles of Asians with NAFLD: A Systematic Review and Meta-Analysis.
Kam LY, Huang DQ, Teng MLP, Takahashi H, Tanaka K, Yasuda S, Fung J, Lee TY, Hyogo H, Ono M, Saruwatari J, Oniki K, Yeo YH, Barnett S, Henry L, Li J, Zou B, Cheung RC, Kumada T, Yuen MF, Eguchi Y, Toyoda H, Nguyen MH. Kam LY, et al. Among authors: tanaka k. Dig Dis. 2022;40(6):734-744. doi: 10.1159/000521662. Epub 2021 Dec 23. Dig Dis. 2022. PMID: 34942625 Free PMC article.
Upper limit of normal serum alanine aminotransferase levels in Japanese subjects.
Tanaka K, Hyogo H, Ono M, Takahashi H, Kitajima Y, Ono N, Eguchi T, Fujimoto K, Chayama K, Saibara T, Anzai K, Eguchi Y; Japan Study Group of Non-alcoholic Fatty Liver Disease (JSG-NAFLD). Tanaka K, et al. Hepatol Res. 2014 Nov;44(12):1196-207. doi: 10.1111/hepr.12293. Epub 2014 Feb 17. Hepatol Res. 2014. PMID: 24372862
Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J).
Eguchi Y, Kitajima Y, Hyogo H, Takahashi H, Kojima M, Ono M, Araki N, Tanaka K, Yamaguchi M, Matsuda Y, Ide Y, Otsuka T, Ozaki I, Ono N, Eguchi T, Anzai K; Japan Study Group for NAFLD (JSG-NAFLD). Eguchi Y, et al. Among authors: tanaka k. Hepatol Res. 2015 Mar;45(3):269-78. doi: 10.1111/hepr.12351. Epub 2014 May 28. Hepatol Res. 2015. PMID: 24796231
Discordant pathological diagnosis of non-alcoholic fatty liver disease: A prospective multicenter study.
Kuwashiro T, Takahashi H, Hyogo H, Ogawa Y, Imajo K, Yoneda M, Nakahara T, Oeda S, Tanaka K, Amano Y, Ogawa S, Kawaguchi A, Aishima S, Kage M, Chayama K, Nakajima A, Eguchi Y. Kuwashiro T, et al. Among authors: tanaka k. JGH Open. 2019 Dec 17;4(3):497-502. doi: 10.1002/jgh3.12289. eCollection 2020 Jun. JGH Open. 2019. PMID: 32514460 Free PMC article.
ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data Validation.
Huang DQ, Yeo YH, Tan E, Takahashi H, Yasuda S, Saruwatari J, Tanaka K, Oniki K, Kam LY, Muthiah MD, Hyogo H, Ono M, Barnett SD, Li J, Zou B, Fung J, Lee TY, Wong VW, Yuen MF, Dan YY, Lim SG, Cheung R, Toyoda H, Eguchi Y, Nguyen MH. Huang DQ, et al. Among authors: tanaka k. Hepatol Commun. 2020 Sep 9;4(11):1624-1636. doi: 10.1002/hep4.1593. eCollection 2020 Nov. Hepatol Commun. 2020. PMID: 33163833 Free PMC article.
Diagnostic Accuracy of FibroScan and Factors Affecting Measurements.
Oeda S, Tanaka K, Oshima A, Matsumoto Y, Sueoka E, Takahashi H. Oeda S, et al. Among authors: tanaka k. Diagnostics (Basel). 2020 Nov 12;10(11):940. doi: 10.3390/diagnostics10110940. Diagnostics (Basel). 2020. PMID: 33198092 Free PMC article. Review.
Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees.
Murayama K, Okada M, Tanaka K, Inadomi C, Yoshioka W, Kubotsu Y, Yada T, Isoda H, Kuwashiro T, Oeda S, Akiyama T, Oza N, Hyogo H, Ono M, Kawaguchi T, Torimura T, Anzai K, Eguchi Y, Takahashi H. Murayama K, et al. Among authors: tanaka k. Diagnostics (Basel). 2021 Jan 16;11(1):132. doi: 10.3390/diagnostics11010132. Diagnostics (Basel). 2021. PMID: 33467114 Free PMC article.
The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040.
Ito T, Ishigami M, Zou B, Tanaka T, Takahashi H, Kurosaki M, Maeda M, Thin KN, Tanaka K, Takahashi Y, Itoh Y, Oniki K, Seko Y, Saruwatari J, Kawanaka M, Atsukawa M, Hyogo H, Ono M, Ogawa E, Barnett SD, Stave CD, Cheung RC, Fujishiro M, Eguchi Y, Toyoda H, Nguyen MH. Ito T, et al. Among authors: tanaka k, tanaka t. Hepatol Int. 2021 Apr;15(2):366-379. doi: 10.1007/s12072-021-10143-4. Epub 2021 Feb 12. Hepatol Int. 2021. PMID: 33580453
Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD.
Takahashi H, Kessoku T, Kawanaka M, Nonaka M, Hyogo H, Fujii H, Nakajima T, Imajo K, Tanaka K, Kubotsu Y, Isoda H, Oeda S, Kurai O, Yoneda M, Ono M, Kitajima Y, Tajiri R, Takamori A, Kawaguchi A, Aishima S, Kage M, Nakajima A, Eguchi Y, Anzai K. Takahashi H, et al. Among authors: tanaka k. Hepatol Commun. 2022 Jan;6(1):120-132. doi: 10.1002/hep4.1696. Epub 2021 Jun 17. Hepatol Commun. 2022. PMID: 34558835 Free PMC article. Clinical Trial.
18,322 results
You have reached the last available page of results. Please see the User Guide for more information.